In vitro enhancement of dendritic cell-mediated anti-glioma immune response by graphene oxide

被引:22
作者
Wang, Wei [1 ,2 ,3 ]
Li, Zhongjun [4 ]
Duan, Jinhong [2 ,3 ]
Wang, Chen [4 ]
Fang, Ying [4 ]
Yang, Xian-Da [2 ,3 ]
机构
[1] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing 100044, Peoples R China
[2] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China
[3] Peking Union Med Coll, Beijing 100005, Peoples R China
[4] Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China
来源
NANOSCALE RESEARCH LETTERS | 2014年 / 9卷
关键词
Glioma; Dendritic cell; DC; Graphene oxide; GO; Immunotherapy; MALIGNANT GLIOMA; SURVIVIN; PROTEIN; VACCINATION; EXPRESSION; IDENTIFICATION; GLIOBLASTOMA; INHIBITOR; DELIVERY; LYSATE;
D O I
10.1186/1556-276X-9-311
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Malignant glioma has extremely poor prognosis despite combination treatments with surgery, radiation, and chemotherapy. Dendritic cell (DC)-based immunotherapy may potentially serve as an adjuvant treatment of glioma, but its efficacy generally needs further improvement. Here we explored whether graphene oxide (GO) nanosheets could modulate the DC-mediated anti-glioma immune response in vitro, using the T98G human glioma cell line as the study model. Pulsing DCs with a glioma peptide antigen (Ag) generated a limited anti-glioma response compared to un-pulsed DCs. Pulsing DCs with GO alone failed to produce obvious immune modulation effects. However, stimulating DCs with a mixture of GO and Ag (GO-Ag) significantly enhanced the anti-glioma immune reaction (p < 0.05). The secretion of interferon gamma (IFN-gamma) by the lymphocytes was also markedly boosted by GO-Ag. Additionally, the anti-glioma immune response induced by GO-Ag appeared to be target-specific. Furthermore, at the concentration used in this study, GO exhibited a negligible effect on the viability of the DCs. These results suggested that GO might have potential utility for boosting a DC-mediated anti-glioma immune response.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 37 条
[1]  
Afra D, 2002, LANCET, V359, P1011
[2]  
Andersen MH, 2001, CANCER RES, V61, P869
[3]   Chitosan-Functionalized Graphene Oxide as a Nanocarrier for Drug and Gene Delivery [J].
Bao, Hongqian ;
Pan, Yongzheng ;
Ping, Yuan ;
Sahoo, Nanda Gopal ;
Wu, Tongfei ;
Li, Lin ;
Li, Jun ;
Gan, Leong Huat .
SMALL, 2011, 7 (11) :1569-1578
[4]  
Brossart MDP, 2002, TRANSFUS APHER SCI, V27, P183
[5]   Quantitatively determined survivin expression levels are of prognostic value in human gliomas [J].
Chakravarti, A ;
Noll, E ;
Black, PM ;
Finkelstein, DF ;
Finkelstein, DM ;
Dyson, NJ ;
Loeffler, JS .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) :1063-1068
[6]   Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas [J].
Ciesielski, Michael J. ;
Apfel, Lisa ;
Barone, Tara A. ;
Castro, Carla A. ;
Weiss, Tina C. ;
Fenstermaker, Robert A. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (12) :1491-1503
[7]   The rise of graphene [J].
Geim, A. K. ;
Novoselov, K. S. .
NATURE MATERIALS, 2007, 6 (03) :183-191
[8]   Treatment of malignant glioma: a problem beyond the margins of resection [J].
Giese, A ;
Westphal, M .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (04) :217-225
[9]   A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes [J].
Haas, C ;
Lulei, M ;
Fournier, P ;
Arnold, A ;
Schirrmacher, V .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (03) :658-667
[10]   THE FALLACY OF THE LOCALIZED SUPRATENTORIAL MALIGNANT GLIOMA [J].
HALPERIN, EC ;
BURGER, PC ;
BULLARD, DE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (02) :505-509